226 related articles for article (PubMed ID: 7819721)
1. Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.
Lindahl G; Mailly F; Humphries S; Seed M
Clin Investig; 1994 Aug; 72(8):631-8. PubMed ID: 7819721
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) in homozygous familial hypercholesterolemia.
Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652
[TBL] [Abstract][Full Text] [Related]
4. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
5. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) Mass Levels Increase Significantly According to
Moriarty PM; Varvel SA; Gordts PL; McConnell JP; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):580-588. PubMed ID: 28062489
[TBL] [Abstract][Full Text] [Related]
7. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
Soutar AK; McCarthy SN; Seed M; Knight BL
J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of the atherogenic Lp(a) are elevated in FH.
Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
[TBL] [Abstract][Full Text] [Related]
10. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
[TBL] [Abstract][Full Text] [Related]
11. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.
Vohl MC; Gaudet D; Moorjani S; Tremblay G; Perron P; Gagné C; Lesiège D; Bergeron J; Lupien PJ; Després JP
Eur J Clin Invest; 1997 May; 27(5):366-73. PubMed ID: 9179542
[TBL] [Abstract][Full Text] [Related]
13. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
14. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
16. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2.
Huang Y; Rall SC; Mahley RW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2817-24. PubMed ID: 9409260
[TBL] [Abstract][Full Text] [Related]
18. The relation of LDL receptor activity to lipoprotein(a) plasma concentration in patients without coronary artery disease.
Ghiselli G; Gaddi A
Chem Phys Lipids; 1994 Jan; 67-68():305-11. PubMed ID: 8187228
[TBL] [Abstract][Full Text] [Related]
19. Effects of apoE gene polymorphism on Lp(a) concentrations depend on the size of apo(a): a study of 466 white men.
Klausen IC; Gerdes LU; Hansen PS; Lemming L; Gerdes C; Faergeman O
J Mol Med (Berl); 1996 Nov; 74(11):685-90. PubMed ID: 8956154
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a).
de Knijff P; Kaptein A; Boomsma D; Princen HM; Frants RR; Havekes LM
Atherosclerosis; 1991 Oct; 90(2-3):169-74. PubMed ID: 1836947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
